NorthCoast Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
NorthCoast Asset Management's PFE Position: Q3 2021 in Review
NorthCoast Asset Management increased its Pfizer (PFE) stake by 0.4% in Q3 2021, buying an estimated $111K and bringing the position to 622,611 shares worth $26.8M. The position accounts for 0.98% of the portfolio, ranked #26.
NorthCoast Asset Management first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. The position peaked at $71.3M in Q4 2014. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.
- NorthCoast Asset Management held 622,611 shares of Pfizer worth $26.8M as of Q3 2021.
- NorthCoast Asset Management bought 2,505 Pfizer shares in Q3 2021, an estimated $111K.
- Pfizer made up 0.98% of NorthCoast Asset Management's portfolio in Q3 2021, its #26 holding.
- NorthCoast Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
- NorthCoast Asset Management's Pfizer position peaked at $71.3M in Q4 2014.
- 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.
Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.